Centerpoint Advisors, LLC Merck & Co., Inc. Transaction History

Centerpoint Advisors, LLC

$288 Million
Q3 2024

A detailed history of Centerpoint Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 1,613 shares of MRK stock, worth $159,977. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,613

Previous 2,302 29.93%

Holding current value

$159,977

Previous $285,000 35.79%

% of portfolio

0.06%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$111.15 - $128.97 $76,582 - $88,860	-689 Reduced 29.93%	1,613 $183,000
Q2 2024 Jul 30, 2024	BUY	$123.8 - $132.96 $18,570 - $19,944	150 Added 6.97%	2,302 $285,000
Q1 2024 May 02, 2024	SELL	$113.24 - $131.95 $12,682 - $14,778	-112 Reduced 4.95%	2,152 $284,000
Q4 2023 Jan 16, 2024	SELL	$100.18 - $109.02 $54,497 - $59,306	-544 Reduced 19.37%	2,264 $247,000
Q3 2023 Nov 01, 2023	BUY	$102.95 - $114.33 $10,295 - $11,433	100 Added 3.69%	2,808 $289,000
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $77,438 - $84,404	713 Added 35.74%	2,708 $312,000
Q1 2023 May 03, 2023	BUY	$102.94 - $114.86 $46,117 - $51,457	448 Added 28.96%	1,995 $212,000
Q4 2022 Jan 24, 2023	BUY	$87.44 - $112.11 $10,930 - $14,013	125 Added 8.79%	1,547 $172,000
Q3 2022 Oct 13, 2022	SELL	$84.53 - $94.96 $5,071 - $5,697	-60 Reduced 4.05%	1,422 $122,000
Q1 2022 Apr 27, 2022	BUY	$73.51 - $82.4 $1,102 - $1,236	15 Added 1.02%	1,482 $122,000
Q3 2021 Oct 25, 2021	BUY	$71.68 - $78.83 $3,584 - $3,941	50 Added 3.53%	1,467 $110,000
Q2 2021 Jul 26, 2021	SELL	$70.31 - $77.77 $10,546 - $11,665	-150 Reduced 9.57%	1,417 $110,000
Q3 2020 Oct 13, 2020	BUY	$73.18 - $82.95 $2,488 - $2,820	34 Added 2.22%	1,567 $130,000
Q2 2020 Jul 31, 2020	SELL	$70.42 - $80.13 $44,153 - $50,241	-627 Reduced 29.03%	1,533 $119,000
Q1 2020 Apr 23, 2020	BUY	$63.36 - $87.82 $43,845 - $60,771	692 Added 47.14%	2,160 $166,000
Q4 2019 Jan 14, 2020	SELL	$77.58 - $87.54 $6,827 - $7,703	-88 Reduced 5.66%	1,468 $134,000
Q3 2019 Oct 21, 2019	SELL	$76.08 - $82.93 $33,855 - $36,903	-445 Reduced 22.24%	1,556 $131,000
Q2 2019 Jul 17, 2019	SELL	$69.84 - $81.59 $5,238 - $6,119	-75 Reduced 3.61%	2,001 $168,000
Q4 2018 Feb 05, 2019	SELL	$65.24 - $75.71 $50,626 - $58,750	-776 Reduced 27.21%	2,076 $159,000
Q3 2018 Nov 08, 2018	SELL	$57.69 - $67.84 $4,038 - $4,748	-70 Reduced 2.4%	2,852 $202,000
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $28,871 - $33,920	-568 Reduced 16.28%	2,922 $177,000
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $12,892 - $14,985	253 Added 7.82%	3,490 $190,000
Q4 2017 Mar 14, 2018	BUY	$51.62 - $61.64 $167,093 - $199,528	3,237	3,237 $182,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.

Account

Centerpoint Advisors, LLC Merck & Co., Inc. Transaction History